RxSight, Inc. logo RXST - RxSight, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $10.25 DETAILS
HIGH: $11.00
LOW: $9.00
MEDIAN: $10.50
CONSENSUS: $10.25
UPSIDE: 68.45%
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 134.5 139.9 89.1 49.0 22.6 14.7 2.2
Cost of Revenue 31.5 41.0 35.3 27.7 18.1 13.0 4.1
Gross Profit 103.0 98.9 53.8 21.3 4.5 1.7 (1.8)
Operating Expenses
R&D Expenses 38.5 34.4 29.1 26.0 24.5 21.9 29.6
SG&A Expenses 112.6 101.4 74.8 58.7 32.8 15.2 15.2
Other Expenses 0 0 0 0 0 0 (0.5)
Operating Expenses 151.2 135.8 103.8 84.6 57.3 37.1 44.3
Operating Income
Operating Income (48.2) (36.9) (50.1) (63.3) (52.8) (35.4) (46.1)
Interest Expense 0.0 0.0 3.3 4.9 3.7 0.5 0.0
Interest Income 2.5 9.5 6.6 1.5 0.1 0.5 2.3
Profitability
EBITDA (39.6) (23.8) (41.0) (57.8) (41.0) 32.2 130.2
EBIT (38.8) (27.4) (45.3) (61.8) (45.0) 28.1 126.3
Income Before Tax (38.9) (27.4) (48.6) (66.7) (48.7) 27.6 126.2
Income Tax Expense 0.1 0.1 0.0 0.0 0.0 0.1 0.0
Net Income (38.9) (27.5) (48.6) (66.8) (48.7) 27.6 126.2
Per Share Data
EPS (Basic) -0.95 -0.71 -1.41 -2.41 -1.78 0.18 0.95
EPS (Diluted) -0.95 -0.71 -1.41 -2.41 -1.78 0.18 6.62
Shares Outstanding 41.2 38.9 34.5 27.7 27.4 19.1 19.1
Metric 2025 2024 2023 2022 2021 2020 2019
Current Assets
Cash & Cash Equivalents 19.9 16.7 9.7 11.8 24.4 14.0 8.0
Short-Term Investments 208.2 220.5 117.5 94.0 135.0 55.0 72.7
Net Receivables 23.4 30.1 20.3 11.0 4.9 2.9 0.8
Inventory 31.6 22.0 17.4 14.8 8.0 8.3 7.2
Other Current Assets 4.4 4.5 3.5 3.0 0 0 0
Total Current Assets 287.5 293.8 168.4 134.6 176.3 81.5 90.2
Non-Current Assets
Property, Plant & Equipment 23.0 23.6 13.3 14.1 15.5 18.6 19.2
Goodwill 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Long-Term Investments 0 0.8 0.7 0 0 0 0
Other Non-Current Assets 1.3 0.4 0.1 1.5 0.9 0.6 1.0
Total Non-Current Assets 24.4 24.7 14.1 15.6 16.4 19.2 20.2
Total Assets 311.8 318.6 182.6 150.2 192.7 100.7 110.4
Current Liabilities
Account Payables 5.3 4.5 3.9 2.6 1.7 1.1 2.2
Short-Term Debt 1.2 0 0 0 0 0 0
Deferred Revenue 0 3.1 2.0 1.3 0.6 0.4 0.4
Other Current Liabilities 19.8 17.2 2.6 10.9 6.9 8.8 4.9
Total Current Liabilities 26.3 25.9 20.9 17.2 11.1 11.6 8.5
Non-Current Liabilities
Long-Term Debt 9.9 0 0 40.2 39.8 24.4 0
Deferred Tax Liabilities 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0.1 0.1 0 0 357.1 402.1
Total Non-Current Liabilities 9.9 11.4 1.3 43.0 43.4 386.6 406.6
Total Liabilities 36.1 37.3 22.2 60.3 54.5 398.2 415.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 80.8 56.4
Retained Earnings (661.0) (622.1) (594.6) (546.0) (479.3) (430.6) (419.9)
Accumulated Other Comprehensive Income 0.1 0.2 (0.0) (0.1) (0.0) (0.0) 0.0
Total Stockholders' Equity 275.7 281.2 160.4 89.9 138.2 (297.5) (304.6)
Total Liabilities & Equity 311.8 318.6 182.6 150.2 192.7 100.7 110.4
Debt Metrics
Total Debt 11.0 12.3 3.0 45.0 44.9 30.8 5.5
Net Debt (8.9) (4.4) (6.7) 33.2 20.6 16.8 (2.4)
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income 0 (27.5) (48.6) (66.8) (48.7) 27.6 126.2
Depreciation & Amortization 0 3.6 4.2 4.0 4.0 4.0 3.9
Stock-Based Compensation 0 24.6 15.7 11.4 7.6 4.2 4.6
Change in Working Capital (4.9) (9.2) (9.1) (7.4) (2.7) (7.8) (4.0)
Other Non-Cash Items (10.6) (8.5) (3.9) (0.1) 0.5 0.1 (171.4)
Operating Cash Flow (15.5) (16.9) (41.6) (58.9) (44.7) (35.2) (40.6)
Investing Activities
Capital Expenditure (3.8) (5.4) (4.8) (2.4) (1.9) (2.5) (4.1)
Acquisitions 0 0 17.3 (42.3) 80.0 0.0 0.6
Purchases of Investments (239.3) (336.9) (272.3) (212.7) (160.0) (97.9) (132.4)
Sales/Maturities of Investments 260 243 255 255 80 116 130
Other Investing Activities 0 0 (17.3) 42.3 (80.0) 0 0
Investing Cash Flow 16.9 (99.3) (22.1) 40.0 (81.9) 15.6 (5.9)
Financing Activities
Net Debt Issuance (0.0) (0.1) (40.2) (0.1) 15.0 24.9 (0.2)
Stock Repurchased 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities (2.1) (5.5) (4.3) (1.4) 1.2 (0.6) 1.5
Financing Cash Flow 1.9 123.3 61.5 6.3 137.3 25.2 1.3
Cash Position
Net Change in Cash 3.2 7.1 (2.2) (12.6) 10.7 5.6 (45.2)
Cash at Beginning 16.7 10.4 12.6 25.2 14.5 8.8 54.0
Cash at End 19.9 17.5 10.4 12.6 25.2 14.5 8.8
Free Cash Flow (19.3) (22.4) (46.4) (61.2) (46.6) (37.7) (44.7)
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 134.5 139.9 89.1 49.0 22.6 14.7 2.2
Gross Profit 103.0 98.9 53.8 21.3 4.5 1.7 (1.8)
Operating Income (48.2) (36.9) (50.1) (63.3) (52.8) (35.4) (46.1)
Net Income (38.9) (27.5) (48.6) (66.8) (48.7) 27.6 126.2
EPS (Diluted) -0.95 -0.71 -1.41 -2.41 -1.78 0.18 6.62
Balance Sheet
Cash & Equivalents 19.9 16.7 9.7 11.8 24.4 14.0 8.0
Total Assets 311.8 318.6 182.6 150.2 192.7 100.7 110.4
Total Debt 11.0 12.3 3.0 45.0 44.9 30.8 5.5
Stockholders' Equity 275.7 281.2 160.4 89.9 138.2 (297.5) (304.6)
Cash Flow
Operating Cash Flow (15.5) (16.9) (41.6) (58.9) (44.7) (35.2) (40.6)
Capital Expenditure (3.8) (5.4) (4.8) (2.4) (1.9) (2.5) (4.1)
Free Cash Flow (19.3) (22.4) (46.4) (61.2) (46.6) (37.7) (44.7)